203 related articles for article (PubMed ID: 11999550)
21. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.
Bellamy WT; Richter L; Frutiger Y; Grogan TM
Cancer Res; 1999 Feb; 59(3):728-33. PubMed ID: 9973224
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
[TBL] [Abstract][Full Text] [Related]
23. Biology of angiogenesis in tumors of the gastrointestinal tract.
Reinmuth N; Parikh AA; Ahmad SA; Liu W; Stoeltzing O; Fan F; Takeda A; Akagi M; Ellis LM
Microsc Res Tech; 2003 Feb; 60(2):199-207. PubMed ID: 12539174
[TBL] [Abstract][Full Text] [Related]
24. The role of VEGF in normal and neoplastic hematopoiesis.
Gerber HP; Ferrara N
J Mol Med (Berl); 2003 Jan; 81(1):20-31. PubMed ID: 12545246
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma.
Ho CL; Sheu LF; Li CY
Ann Diagn Pathol; 2003 Feb; 7(1):1-8. PubMed ID: 12616467
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.
Nakamura S; Murakami-Mori K; Rao N; Weich HA; Rajeev B
J Immunol; 1997 May; 158(10):4992-5001. PubMed ID: 9144519
[TBL] [Abstract][Full Text] [Related]
27. VEGF and the quest for tumour angiogenesis factors.
Ferrara N
Nat Rev Cancer; 2002 Oct; 2(10):795-803. PubMed ID: 12360282
[TBL] [Abstract][Full Text] [Related]
28. Multiple angiogenesis stimulators in a single malignancy: implications for anti-angiogenic tumour therapy.
Pavlakovic H; Havers W; Schweigerer L
Angiogenesis; 2001; 4(4):259-62. PubMed ID: 12197470
[TBL] [Abstract][Full Text] [Related]
29. Angiogenesis in hematologic malignancies.
Mesters RM
Ann Hematol; 2002; 81 Suppl 2():S72-4. PubMed ID: 12611085
[No Abstract] [Full Text] [Related]
30. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
Dias S; Hattori K; Heissig B; Zhu Z; Wu Y; Witte L; Hicklin DJ; Tateno M; Bohlen P; Moore MA; Rafii S
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10857-62. PubMed ID: 11553814
[TBL] [Abstract][Full Text] [Related]
31. Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate.
Doll JA; Reiher FK; Crawford SE; Pins MR; Campbell SC; Bouck NP
Prostate; 2001 Dec; 49(4):293-305. PubMed ID: 11746276
[TBL] [Abstract][Full Text] [Related]
32. [Angiogenesis and hematologic malignancy].
Zini JM; Tobelem G
Bull Cancer; 2007 Jul; 94 Spec No():S241-6. PubMed ID: 17846010
[TBL] [Abstract][Full Text] [Related]
33. Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor.
Graeven U; Rodeck U; Karpinski S; Jost M; Philippou S; Schmiegel W
Cancer Res; 2001 Oct; 61(19):7282-90. PubMed ID: 11585767
[TBL] [Abstract][Full Text] [Related]
34. Trophic effects of platelets on cultured endothelial cells are mediated by platelet-associated fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF).
Pintucci G; Froum S; Pinnell J; Mignatti P; Rafii S; Green D
Thromb Haemost; 2002 Nov; 88(5):834-42. PubMed ID: 12428103
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor and its receptors in multiple myeloma.
Ria R; Roccaro AM; Merchionne F; Vacca A; Dammacco F; Ribatti D
Leukemia; 2003 Oct; 17(10):1961-6. PubMed ID: 14513045
[TBL] [Abstract][Full Text] [Related]
36. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production.
Fusetti L; Pruneri G; Gobbi A; Rabascio C; Carboni N; Peccatori F; Martinelli G; Bertolini F
Cancer Res; 2000 May; 60(9):2527-34. PubMed ID: 10811135
[TBL] [Abstract][Full Text] [Related]
37. [Study of the changes and effect of VEGF and bFGF in early stage of maxillofacial blast injury in rabbits].
Zhang C; Li H; Zhou S; Yang J
Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Apr; 19(2):77-9, 82. PubMed ID: 12539415
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of the determination of angiogenic factors.
Toi M; Taniguchi T; Yamamoto Y; Kurisaki T; Suzuki H; Tominaga T
Eur J Cancer; 1996 Dec; 32A(14):2513-9. PubMed ID: 9059341
[No Abstract] [Full Text] [Related]
39. Endothelial stimulation by small lymphocytic lymphoma correlates with secreted levels of basic fibroblastic growth factor.
Rimsza L; Pastos K; Massey K; Braylan R
Br J Haematol; 2003 Mar; 120(5):753-8. PubMed ID: 12614205
[TBL] [Abstract][Full Text] [Related]
40. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
